AGGIES LabBLOCKMINE

Evidence graph

Sources, insights, and the research program

The drawing shows citation edges only: which operational source supports which derived insight. The edge list below adds insight-to-insight associations and the dashed, hypothesis-class links between the Blockchain Mining research themes and the modules.

SOURCES (5)DERIVED INSIGHTS (7)CISA Known Exploited Vulnerabilities1,769 records · 2026-11-08FIRST EPSS400 records · 2026-11-08ClinicalTrials.gov API v2400 records · 2026-11-08openFDA Drug Shortages1,598 records · 2026-11-08OpenAlex200 records · 2026-11-08KEV additions, trailing 90 daysCyber · high confidenceRecent KEV × EPSS ≥ 0.5Cyber · moderate confidenceRegistrations per conditionHealthcare · high confidenceCurrent FDA shortage entriesHealthcare · high confidenceOpen-problem phrase matchesBusiness Ideas · moderate confidenceStated shortage reasonsSupply Chain · moderate confidenceShortage-posting HHISupply Chain · low confidence
8 citation edges · maroon = opportunity module, graphite = threat module · computed from the published insights; identical to the edge list

Edge list

28 edges · 8 citation · 20 association or contextualExport CSV
Evidence graph edges
FromToRelationshipEvidence classProvenance
source:cisa_kevinsight:kev-additions-last-90-dayssupportsderivedhttps://www.cisa.gov/known-exploited-vulnerabilities-catalog
insight:kev-additions-last-90-daysinsight:kev-epss-high-probability-setassociated_withderivedshared source or topic
source:cisa_kevinsight:kev-epss-high-probability-setsupportsderivedhttps://www.cisa.gov/known-exploited-vulnerabilities-catalog
source:first_epssinsight:kev-epss-high-probability-setsupportsderivedhttps://www.first.org/epss/data
insight:kev-epss-high-probability-setinsight:kev-additions-last-90-daysassociated_withderivedshared source or topic
source:clinicaltrials_govinsight:registered-studies-per-conditionsupportsderivedhttps://clinicaltrials.gov/data-api/api
insight:registered-studies-per-conditioninsight:drug-shortages-current-by-categoryassociated_withderivedshared source or topic
source:openfda_drug_shortagesinsight:drug-shortages-current-by-categorysupportsderivedhttps://open.fda.gov/apis/drug/drugshortages/
insight:drug-shortages-current-by-categoryinsight:current-shortage-reasonsassociated_withderivedshared source or topic
insight:drug-shortages-current-by-categoryinsight:registered-studies-per-conditionassociated_withderivedshared source or topic
source:openalexinsight:open-problem-phrase-matches-by-sectorsupportsderivedhttps://help.openalex.org/api/
source:openfda_drug_shortagesinsight:current-shortage-reasonssupportsderivedhttps://open.fda.gov/apis/drug/drugshortages/
insight:current-shortage-reasonsinsight:shortage-posting-manufacturer-concentrationassociated_withderivedshared source or topic
insight:current-shortage-reasonsinsight:drug-shortages-current-by-categoryassociated_withderivedshared source or topic
source:openfda_drug_shortagesinsight:shortage-posting-manufacturer-concentrationsupportsderivedhttps://open.fda.gov/apis/drug/drugshortages/
insight:shortage-posting-manufacturer-concentrationinsight:current-shortage-reasonsassociated_withderivedshared source or topic
research_theme:Public-Chain Data Collectionmodule:Business Ideas for Open Problemscontextual_research_linkhypothesisOpen data infrastructure and indexing as venture hypotheses.
research_theme:Public-Chain Data Collectionmodule:Cyber Vulnerabilitiescontextual_research_linkhypothesisNode and RPC software only when a catalog entry exists.
research_theme:Adoption and Activity Signalsmodule:Business Ideas for Open Problemscontextual_research_linkhypothesisRecurring on-chain failures and tooling gaps as open-problem candidates.
research_theme:Adoption and Activity Signalsmodule:Supply Chain Weaknessescontextual_research_linkhypothesisDependence on a few RPC providers and indexers as a software dependency.
research_theme:Provenance and Real-World Assetsmodule:Supply Chain Weaknessescontextual_research_linkhypothesisPublic provenance records as one traceability input; no inferred private supplier edge.
research_theme:Provenance and Real-World Assetsmodule:Healthcarecontextual_research_linkhypothesisPublicly posted pharmaceutical provenance records; research intelligence only.
research_theme:Exploits and Contract Weaknessesmodule:Cyber Vulnerabilitiescontextual_research_linkhypothesisMapped to published weakness classes; an exploit is not a CVE unless one exists.
research_theme:Exploits and Contract Weaknessesmodule:Business Ideas for Open Problemscontextual_research_linkhypothesisAudit, monitoring, and recovery tooling gaps.
research_theme:Concentration and Systemic Dependencymodule:Supply Chain Weaknessescontextual_research_linkhypothesisBridge, issuer, and oracle concentration as systemic dependency.
research_theme:Concentration and Systemic Dependencymodule:Cyber Vulnerabilitiescontextual_research_linkhypothesisSingle points of failure as attack-surface context, not exposure claims.
research_theme:Ethics, Legality, and Reproducibilitymodule:Business Ideas for Open Problemscontextual_research_linkhypothesisPrivacy-preserving analytics and licensed dataset tooling.
research_theme:Ethics, Legality, and Reproducibilitymodule:Cyber Vulnerabilitiescontextual_research_linkhypothesisDisclosure norms as context for dated weakness claims.